Topic Index

Topic Index

Breast Health

Topic Index Clinical Assessment; 0408 Topic Index Decision-Making and Support Styles Assessment; 0409 General Education Extravasation Assessment; 0410 Antiperspirants and Breast Cancer; 0101 Female Sexual Function Index (FSFI)©; 0411 Bra Fitting; 0102 Female Sexual Function Index (FSFI)© Scoring; 0412 Breast Cancer Facts; 0103 Updated General Pain Assessment; 0413 Breast Cancer Misconceptions and Facts; 0104 General Pain: Daily Self-Assessment; 0414 Breast Cancer Statistics; 0105 Updated I’ve Found a Lump: Preparing for Physician’s Exam; Breast Self-Exam; 0106 0415 Caffeine Connection; 0107 Lymphedema Assessment; 0416 Frequently Asked Questions About the ; 0108 Male Breast Health Assessment; 0417 Mood Assessment: Post-Diagnosis; 0418 Breast Anatomy Graphics Mood Assessment: Post-Treatment; 0419 Breast Anatomy - Female; 0201 Patient Support Needs Assessment; 0420 Breast Anatomy - Male; 0206 Quality of Life Assessment; 0421 Breast Anatomy - Male and Female Comparison; Range of Motion Assessment (Female Patient); 0422 0207 Range of Motion Assessment (Male Patient); 0426 Breast Diagram - Female; 0202 Resource Needs Assessment; 0423 Breast Diagram - Male; 0208 Treatment Side Effects Calendar Record; 0424 Female Breast and Breast Diagram; 0203 Vital Signs Record; 0425 Internal Female Breast Diagram; 0204 Stages of Nodularity; 0205 Procedures 3-D — ; 0515 Mammography Forms and Letters ABUS (Automated Breast Screening); Abnormal Mammogram: Biopsy Recommended; 0517 0301 Additional Mammography Views: Spot Compression Abnormal Mammogram: Follow-Up Self Referral; and Magnification; 0501 0302 Breast-Specific Gamma Imaging (BSGI); 0502 Abnormal Mammogram: Immediate Follow-Up; 0303 Calcifications - Microcalcifications; 0503 Diagnostic Mammogram: Normal Results; 0304 Compression During Mammography; 0504 Mammography Consent Form; 0305 Digital Mammography; 0505 Updated Mammography Scheduling Questionnaire; 0306 Galactography; 0506 Updated Requesting Your Mammography Film; 0307 Implants and Mammography; 0507 Screening Mammography: Results; 0308 Magnetic Resonance Imaging (MRI) of the Breast (Female Patient); 0508 Assessment Tools Magnetic Resonance Imaging (MRI) of the Breast Adjusting to Loss Assessment; 0401 (Male Patient); 0516 Anxiety Assessment; 0402 Mammography Exam: Patient Overview; 0509 Biopsy: Pre/Post Assessment; 0403 Mammography Report From Radiologist; 0510 Blood Products Transfusion Assessment; 0404 Mammography Report Terminology; 0511 Breast Abnormality Patient Referral; 0405 Methylene Blue Dye Localization; 0512 Breast Pain Assessment; 0406 Obtaining the Optimal Mammogram; 0513 Breast Patient: Clinical Referral; 0407 Radiation Exposure Concerns; 0514

© 2021 page 1 of 8 Biopsy Procedures Radial Scar; 0719 Biopsy Risks; 0601 Sclerosing Adenosis; 0720 Biopsy Types: Overview; 0602 Shingles (Herpes Zoster); 0721 : Patient Instructions (Female Patient); 0603 Breast Cancer Characteristics Breast Biopsy: Patient Instructions (Male Patient); Breast Cancer Growth Rate: How Long Has It Been 0620 There?; 0801 Core Needle Biopsy; 0604 Cancer Growth Rate; 0802 EnCapsule Biopsy; 0605 Cancer Progression Process; 0803 Excisional Biopsy; 0606 Estrogen and Progesterone Receptor Status; 0804 Fine Needle Aspiration (FNA); 0607 Grading of Invasive Breast Cancer; 0805 Fine Needle Aspiration (FNA) of a Cyst; 0608 Pathology Report; 0806 Incisional Biopsy; 0609 Stages of Breast Cancer; 0807 IntactTM Biopsy; 0610 Staging of Breast Cancer: Patient Explanation; 0808 Large Core Biopsy — ABBI®; 0611 Triple-Negative Breast Cancer (TNBC); 0812 NEW Magnetic Resonance Breast Imaging (MRI): Breast Tumor Markers; 0809 Biopsy; 0612 What Is Breast Cancer? (Female Patient); 0810 Magnetic Resonance Breast Imaging (MRI): Needle What Is Breast Cancer? (Male Patient); 0811 Localization; 0613 Mammotome® Breast Biopsy; 0614 Breast Cancer Types Needle Localization (Wire Localization): Breast Apocrine Carcinoma; 0901 Abnormality; 0615 Cancer During Pregnancy: Most Frequently Asked Needle Localization (Wire Localization): Patient Questions; 0902 Instructions; 0616 Carcinoma In Situ: Comedo Pattern; 0903 Skin Punch Biopsy; 0619 (Female Patient); 0905 Stereotactic Breast Biopsy; 0617 Ductal Carcinoma In Situ (Male Patient); 0918 Ultrasound Guided Breast Biopsy; 0618 Ductal Carcinoma In Situ: Surgical Management (Female Patient); 0906 Benign Breast Conditions Ductal Carcinoma In Situ: Surgical Management Accessory Breast Tissue; 0701 (Male Patient); 0919 Atypical Hyperplasia; 0702 Inflammatory Carcinoma (Female Patient); 0909 Breast Abscess; 0703 Inflammatory Carcinoma (Male Patient); 0922 Breast Cellulitis; 0704 Invasive (Infiltrating) Ductal Carcinoma (Female Breast Cysts; 0705 Patient); 0907 Breast Pain (Female Patient); 0706 Invasive (Infiltrating) Ductal Carcinoma (Male Breast Pain (Male Patient); 0725 Patient); 0920 Breast Pain and Tenderness; 0726 Invasive (Infiltrating) Lobular Carcinoma (Female Patient); 0908 Dense Breasts; 0723 Lobular Carcinoma In Situ; 0910 Duct Ectasia - Periductal Mastitis; 0707 Lymphoma of the Breast; 0911 Fat Necrosis Tumor; 0708 Male Breast Cancer; 0912 Fibroadenoma; 0709 Medullary Carcinoma; 0913 Fibrocystic Changes; 0710 Mucinous Carcinoma; 0914 Galactocele; 0711 Paget Disease; 0915 Gynecomastia - Male; 0712 Papillary Carcinoma; 0916 Hamartoma of the Breast; 0722 Phyllodes Tumor — Cystosarcoma; 0904 Itching Breasts; 0713 Tubular Carcinoma; 0917 Lipomas; 0714 Mastitis; 0715 High Risk and Genetic Testing Mondor’s Syndrome; 0716 BRCA Genetic Testing (Female Patient); 1001 (Female Patient); 0717 BRCA Genetic Testing (Male Patient); 1008 Nipple Discharge (Male Patient); 0724 BRCA Genetic Testing: Negative Result (Female Papilloma; 0718 Patient); 1002

© 2021 page 2 of 8 BRCA Genetic Testing: Negative Result (Male / Comparison (Female Patient); 1009 Patient); 1113 BRCA Genetic Testing: Positive Result (Female Lumpectomy/Mastectomy Comparison (Male Patient); 1003 Patient); 1143 BRCA Genetic Testing: Positive Result (Male Patient); Lymphatic System: Understanding Its Role (Female 1010 Patient); 1114 BRCA Genetic Testing: Uncertain Result; 1004 Lymphatic System: Understanding Its Role (Male High Risk Recommended Reading List; 1005 Patient); 1144 High Risk: Lifestyle Modifications (Female Patient); Male Gynecomastia: Surgical Correction; 1115 1006 Mastectomy (Female Patient); 1116 High Risk: Lifestyle Modifications (Male Patient); Mastectomy (Male Patient); 1145 1011 Mastectomy: Discharge Instructions; 1117 I’m High Risk: What Do I Do?; 1007 Medications That Increase Bleeding; 1132 Nipple-Sparing Mastectomy (Female Patient); 1118 Surgery Nipple-Sparing Mastectomy (Male Patient); 1147 Areola-Sparing Mastectomy; 1153 Peripherally Inserted Central Catheter (PICC Line); Breast Cancer Surgery Preparation (Female Patient); 1133 1101 Sentinel Lymph Node Mapping: Why? (Female Breast Cancer Surgery Preparation (Male Patient); Patient); 1119 1137 Sentinel Lymph Node Mapping: Why? (Male Patient); Breast Cancer Surgery: Patient Instructions (Female 1148 Patient); 1102 Sentinel Lymph Node Surgery (Female Patient); Breast Cancer Surgery: Patient Instructions (Male 1120 Patient); 1138 Sentinel Lymph Node Surgery (Male Patient); 1149 Breast Self-Exam After Lumpectomy (Female Seroma; 1121 Patient); 1135 Skin-Sparing Mastectomy; 1122 Breast Self-Exam After Lumpectomy (Male Patient); Surgical Decision: Patient Self-Assessment; 1123 1151 Surgical Incision Care (Female Patient); 1124 Breast Self-Exam After Mastectomy (Female Patient); 1130 Surgical Incision Care (Male Patient); 1150 Breast Self-Exam After Mastectomy (Male Patient); Surgical Incision: Infection; 1125 1152 Tissue Necrosis: Debridement; 1126 Chemotherapy Central Line: Central Intravenous Vascular Access Catheter Dressing Change; 1127 Port Surgery (Female Patient); 1103 Venipunctures/Blood Pressure Checks: LEFT ARM; Chemotherapy Central Line: Central Intravenous 1128 Port Surgery (Male Patient); 1139 Venipunctures/Blood Pressure Checks: RIGHT ARM; Chemotherapy Central Line: Central Venous Catheter 1129 Surgery (Female Patient); 1104 What Do I Do About My Other Breast?; 1134 Chemotherapy Central Line: Central Venous Catheter Surgery (Male Patient); 1140 Reconstruction Drain Bulb Record; 1105 Abdominal Autologous Reconstruction: Flap Drains: Care and Instructions; 1106 Composition and Blood Supply; 1230 Exercise and Care of the Surgical Arm (Female Autologous Reconstruction (Female Patient); 1201 Patient); 1131 Autologous Reconstruction (Male Patient); 1234 Exercise and Care of the Surgical Arm (Male Breast Augmentation With Implants; 1231 Patient); 1136 -Associated Lymphoma (BIA-ALCL); Hematoma (Female Patient); 1107 1248 Hematoma (Male Patient); 1141 Breast Implants (Female Patient); 1202 Hemorrhage (Bleeding) After ; 1108 Breast Implants (Male Patient); 1235 How Physicians Make Surgical Decisions; 1109 Breast Implants: What Patients Need to Know; 1224 Informed Consent; 1110 Options (Female Patient); Lumpectomy (Female Patient); 1111 1203 Lumpectomy (Male Patient); 1142 Breast Reconstruction Options (Male Patient); 1236 Lumpectomy: Discharge Instructions; 1112 Updated Breast Reconstruction Terms; 1233

© 2021 page 3 of 8 (Mammoplasty); 1232 TRAM Pedicle Flap Breast Reconstruction (Male Capsular Contracture From Breast Implants; 1204 Patient); 1246 DIEP (Deep Inferior Epigastric Perforator) Breast TUG (Transverse Upper Gracilis) Breast Reconstruction (Female Patient); 1205 Reconstruction; 1228 DIEP (Deep Inferior Epigastric Perforator) Breast What Every Patient Needs to Know About Breast Reconstruction (Male Patient); 1237 Implants; 1225 Flap Necrosis After Breast Reconstruction; 1206 Flap Revisions After Breast Reconstruction; 1207 Treatments IGAP (Inferior Gluteal Artery Perforator) Breast 3D-Conformal Radiation; 1337 Reconstruction; 1210 Breast Brachytherapy: Accelerated Partial Breast Immediate or Delayed Reconstruction Decision; Irradiation (APBI); 1302 1208 Breast Brachytherapy: MammoSite®; 1301 Implants With Acellular Dermal Matrix; 1209 Breast Cancer IndexSM (BCI); 1327 Latissimus Dorsi (LD) Breast Reconstruction (Female Cancer Clinical Trials; 1303 Patient); 1211 Chemosensitivity/Chemoresistance Testing; 1305 Latissimus Dorsi (LD) Breast Reconstruction (Male Chemotherapy Drugs and Schedules; 1306 Patient); 1238 Chemotherapy or Hormonal Therapy: Why Do I — Breast-Lift Surgery; 1213 Need It?; 1307 Nipple and Areola Reconstruction; 1214 Chemotherapy: Evaluating Cancer’s Response; 1308 Nipple and Areola Tattooing; 1215 Chemotherapy: How Can We Tell If It’s Working?; Nipple-Sharing Reconstruction; 1247 1309 PAP (Profunda Artery Perforator) Breast Chemotherapy: How It Works; 1310 Reconstruction; 1229 Chemotherapy: How Long Is Treatment Given?; Reconstruction Flap Types (Female Patient); 1216 1311 Reconstruction Flap Types (Male Patient); 1239 Chemotherapy: Patient Infusion Tips; 1312 Reconstructive Surgery: Advantages and Chemotherapy: Patient Questions; 1313 Disadvantages (Female Patient); 1217 Chemotherapy: Regional Delivery Devices; 1314 Reconstructive Surgery: Advantages and Chemotherapy: Targeted Drugs; 1315 Disadvantages (Male Patient); 1240 CONTURA® MLB Catheter: Accelerated Partial Breast Reconstructive Surgery: Criteria and Risk Factors Radiation (APBI); 1338 (Female Patient); 1218 Dose-Dense Chemotherapy; 1316 Update Reconstructive Surgery: Criteria and Risk Factors External Beam Radiation Therapy (Female Patient); (Male Patient); 1241 1339 Reconstructive Surgery: Patient Instructions (Female External Beam Radiation Therapy (Male Patient); Patient); 1219 1335 Reconstructive Surgery: Patient Instructions (Male External Radiation Therapy Tattoos; 1326 Patient); 1242 Hormonal Therapy Overview (Female Patient); 1317 Recovery After Breast Reconstruction; 1220 Hormonal Therapy Overview (Male Patient); 1329 SGAP (Superior Gluteal Artery Perforator) Breast Hormonal Therapy Questions (Female Patient); 1318 Reconstruction; 1221 Hormonal Therapy Questions (Male Patient); 1330 TAP (Thoracodorsal Artery Perforator) Breast Reconstruction (Female Patient); 1222 Immune System During Chemotherapy (Female Patient); 1319 TAP (Thoracodorsal Artery Perforator) Breast Reconstruction (Male Patient); 1243 Immune System During Chemotherapy (Male Patient); 1331 TRAM Free Flap Breast Reconstruction (Female Patient); 1226 Intraoperative Breast Radiation; 1343 ® TRAM Free Flap Breast Reconstruction (Male MammaPrint ; 1328 Patient); 1244 MammoSite®: Accelerated Partial Breast Irradiation TRAM Muscle-Sparing Free Flap Breast (APBI); 1341 Reconstruction (Female Patient); 1227 Medical Oncologist and Your Treatment Plan (Female TRAM Muscle-Sparing Free Flap Breast Patient); 1320 Reconstruction (Male Patient); 1245 Medical Oncologist and Your Treatment Plan (Male TRAM Pedicle Flap Breast Reconstruction (Female Patient); 1332 Patient); 1223 Neoadjuvant Chemotherapy; 1321

© 2021 page 4 of 8 Oncotype DXTM Breast Recurrence Score: DCIS; Chemotherapy: Patient Symptoms to Report; 1420 1336 Constipation; 1421 Oncotype DXTM Breast Recurrence Score: Invasive Costochondritis; 1422 Breast Cancer; 1322 Cough During Chemotherapy; 1423 Radiation Oncologist and Radiation Therapy (Female Deep Vein Thrombosis (DVT); 1424 Patient); 1323 Dehydration During Chemotherapy; 1425 Radiation Oncologist and Radiation Therapy (Male Dental Care During Cancer Treatment; 1426 Patient); 1333 Diarrhea; 1427 Radiation Therapy After Mastectomy (Female Patient); 1344 Esophagitis: Inflammation of the Esophagus; 1428 Radiation Therapy After Mastectomy (Male Patient); Extravasation; 1429 1346 Fatigue After Chemotherapy Is Completed; 1430 Radiation Therapy Overview; 1334 Fatigue Management During Treatment; 1431 Radiation Therapy: Side Effects and Skin Care Fecal Impaction; 1432 (Female Patient); 1347 Fertility After Treatment (Female Patient); 1433 Radiation Therapy: Side Effects and Skin Care (Male Fertility After Treatment (Male Patient); 1488 Patient); 1348 Fever During Treatment; 1434 Radiation Therapy: What You Need To Know; 1345 Frozen Shoulder: Adhesive Capsulitis; 1435 TM SAVI Accelerated Partial Breast Irradiation (APBI); Gastritis: Stomach Irritation; 1436 1342 Gastrointestinal Problems During Chemotherapy; Second Opinions; 1324 1437 Thoracentesis; 1325 Hiccups During Treatment; 1438 Understanding Breast Cancer Receptors: Estrogen/ Hives: Urticaria; 1439 Progesterone/HER2; 1349 NEW Hot Flash Management; 1440 Treatment Side Effects Hot Flashes (Female Patient); 1441 Hot Flashes (Male Patient); 1489 Abdominal Pain During Chemotherapy Treatment (Female Patient); 1401 Hypercalcemia: Elevated Blood Calcium; 1442 Abdominal Pain During Chemotherapy Treatment Hyperkalemia: Elevated Blood Potassium Levels; (Male Patient); 1485 1443 Allergic Reaction to Chemotherapy or Drugs; 1402 Hypernatremia: Elevated Blood Sodium Levels; 1444 Alopecia: Hair Loss (Female Patient); 1403 Hyperventilation: Panic Attack; 1445 Alopecia: Hair Loss (Male Patient); 1486 Hypocalcemia: Decreased Blood Calcium Levels; 1446 Anemia: Low Hemoglobin; 1404 Hypokalemia: Decreased Blood Potassium Levels; Anxiety: Recognition & Management During 1447 Treatment; 1405 Hyponatremia: Decreased Sodium Levels; 1448 Appetite Changes During Chemotherapy; 1406 Indigestion: Dyspepsia; 1449 Appetite Stimulation; 1407 Insomnia; 1450 Arthralgia (Joint Pain) From Aromatase Inhibitors; 1408 Jaw Pain With Zometa; 1451 Ascites; 1409 Leukopenia: Low White Blood Cell Count; 1452 Atrophic Vaginitis; 1410 Lymphedema (Female Patient); 1453 Bladder Infection (Female Patient); 1411 Lymphedema (Male Patient); 1490 Bladder Infection (Male Patient); 1487 Lymphedema Management; 1454 Bladder Problems During Chemotherapy; 1412 Lymphedema and Weight-Lifting Exercise; 1455 Blood Clots During Cancer Treatment; 1413 Medications That Increase Bleeding Potential; 1456 Blood Counts: Understanding Their Importance; Memory Problems During Chemotherapy; 1457 1414 Menopausal Side Effects From Chemotherapy; 1458 Blood Sugar Fluctuation Management; 1415 Monitoring for Abnormal Blood Counts; 1459 Candidiasis of the Skin; 1416 Nadir From Chemotherapy; 1460 Care of the Surgical Arm After Breast Surgery; 1417 Nausea and Vomiting Management; 1461 Cellulitis: Infection of the Surgical Arm; 1418 Nausea and Vomiting Tips; 1462 Chemotherapy: Allergic Reaction; 1419 Osteoporosis (Female Patient); 1463

© 2021 page 5 of 8 Osteoporosis (Male Patient); 1491 Ativan® (lorazepam) (Male Patient); 1589 Peripheral Neuropathy: Patient Care; 1464 Avastin® (bevacizumab); 1513 Peripheral Neuropathy: Signs and Symptoms; 1465 BCNU® (carmustine) (Female Patient); 1514 Pneumonia; 1466 BCNU® (carmustine) (Male Patient); 1590 Pulmonary Embolus (PE); 1467 Cytoxan® (cyclophosphamide) (Female Patient); Radiation Recall; 1468 1515 Radiation Therapy: Skin Care (Female Patient); 1470 Cytoxan® (cyclophosphamide) (Male Patient); 1591 Radiation Therapy: Skin Care (Male Patient); 1492 Decadron® (dexamethasone) (Female Patient); 1516 ® Scalp Cooling During Chemotherapy; 1496 NEW Decadron (dexamethasone) (Male Patient); 1592 ® ® Scalp Cooling Haircare Tips; 1497 NEW Ellence , Pharmorubicin PFS (epirubicin) (Female Septicemia: Sepsis; 1471 Patient); 1517 ® ® Sexual Side Effects From Chemotherapy Treatment Ellence , Pharmorubicin PFS (epirubicin) (Male (Male Patient); 1495 Patient); 1584 ® Shingles: Herpes Zoster; 1472 Emend (fosaprepitant dimeglumine); 1558 ® ® ® Stomatitis: Sore Mouth; 1473 Epogen , Procrit , Eprex (epoetin); 1518 ® Taste Alterations During Chemotherapy (Dysgeusia); Evista (raloxifene) (Female Patient); 1561 1474 Evista® (raloxifene) (Male Patient); 1562 Thrombocytopenia: Low Platelet Count (Female Fareston® (toremifene) (Female Patient); 1519 Patient); 1475 Fareston® (toremifene) (Male Patient); 1563 Thrombocytopenia: Low Platelet Count (Male Faslodex® (fulvestrant); 1520 Patient); 1493 Femara® (letrozole) (Female Patient); 1521 Thrush: Oral Candidiasis; 1476 Femara® (letrozole) (Male Patient); 1564 Transfusion of Platelets; 1477 Folex PFS® (methotrexate) (Female Patient); 1522 Transfusion of Red Blood Cells; 1478 Folex PFS® (methotrexate) (Male Patient); 1564 Vaginal Candidiasis: Yeast Infection; 1480 Gemzar® (gemcitabine); 1523 Vaginal Dryness and Painful Intercourse; 1481 Halaven® (eribulin meyslate); 1555 Vaginal Dryness Side Effects; 1482 Halotestin® (fluoxymesterone); 1524 Vital Signs: Patient Instructions; 1483 Herceptin® (trastuzumab); 1525 Weight Gain During Treatment (Female Patient); Ibrance® (palbociclib) (Female Patient); 1559 1484 Ibrance® (palbociclib) (Male Patient); 1565 Weight Gain During Treatment (Male Patient); 1494 Ixempra® (ixabepilone); 1526 Kadcyla® (ado-trastuzumab emtansine; T-DM1) Medications (Female Patient); 1554 ® 5-FU (fluorouracil) (Female Patient); 1501 Kadcyla® (ado-trastuzumab emtansine; T-DM1) 5-FU® (fluorouracil) (Male Patient); 1585 (Male Patient); 1566 Abraxane®; 1502 KEYTRUDA® (pembrolizumab) (Female Patient); Adriamycin® (doxorubicin) (Female Patient); 1503 1595 Adriamycin® (doxorubicin) (Male Patient); 1586 KEYTRUDA® (pembrolizumab) (Male Patient); 1596 Afinitor® (everolimus) (Female Patient); 1556 KISQALI® (ribociclib) (Female Patient); 1597 Afinitor® (everolimus) (Male Patient); 1587 KISQALI® (ribociclib) (Male Patient); 1598 Akynzeo® (netupitant; palonosetron); 1557 Kytril® (granisetron); 1527 Aloxi® (palonosetron HCI); 1504 Lupron®, Lupron Depot®, Viadur®, Leuprorelin® Ambien® (zolpidem) (Female Patient); 1505 (leuprolide) (Female Patient); 1528 Ambien® (zolpidem) (Male Patient); 1588 Lupron®, Lupron Depot®, Viadur®, Leuprorelin® Anzemet® (dolasetron); 1506 (leuprolide) (Male Patient); 1567 ® Aranesp® (darbepoetin alfa); 1507 Lynparza (olaparib) (Female Patient); 15012 ® Aranesp®: Patient Instructions for Self- Lynparza (olaparib) (Male Patient); 15013 Administration; 1508 Marinol® (dronabinol); 1529 Aredia® (pamidronate disodium); 1509 Megace® (megesterol) (Female Patient); 1530 Arimidex® (anastrazole); 1510 Megace® (megesterol) (Male Patient); 1568 Aromasin® (exemestane); 1511 Mutamycin® (mitomycin) (Female Patient); 1531 Ativan® (lorazepam) (Female Patient); 1512 Mutamycin® (mitomycin) (Male Patient); 1569

© 2021 page 6 of 8 Navelbine® (vinorelbine); 1532 Zoladex® (goserelin) (Female Patient); 1550 NERLYNX® (neratinib maleate); 15018 Zoladex® (goserelin) (Male Patient); 1583 Neulasta® (pegfilgrastim); 1553 Zometa® (zoledronic acid); 1551 Neulasta® (pegfilgrastim) On-body Injector: Patient Instructions; 15021 NEW Cancer Diagnostic Tests/Procedures Neumega® (oprelvekin); 1533 Bone Scan Preparation; 1601 Neupogen®, Neutrogin® (filgastrim); 1534 Brain Computed Tomography: CT or CAT Scan; 1602 Nolvadex® (tamoxifen) (Female Patient); 1535 Computed Tomography (CT) Scan; 1603 Nolvadex® (tamoxifen) (Male Patient); 1571 Diagnostic (US); 1609 Oncovin®, Vincasar PFS® (vincristine) (Female Intravenous (IVP): Patient Instructions; Patient); 1536 1604 Oncovin®, Vincasar PFS® (vincristine) (Male Patient); Liver Scan: Patient Instructions; 1605 1572 MRI (Magnetic Resonance Imaging): Patient OPDIVO® (nivolumab) (Female Patient); 1593 Instructions; 1606 OPDIVO® (nivolumab) (Male Patient); 1594 PET (Positron Emission Tomography) Scan: Patient Paraplatin® (carboplatin aqueous solution); 1537 Instructions; 1607 Perjeta® (pertuzumab); 1552 Ultrasound (US); 1608 PIQRAY® (alpelisib) (Female Patient); 15019 PIQRAY® (alpelisib) (Male Patient); 15020 Metastatic Disease Platinol® (cisplatin) (Female Patient); 1538 Bone Metastasis; 1701 Platinol® (cisplatin) (Male Patient); 1573 Brain Metastasis; 1702 Prednisone® (Female Patient); 1539 Cancer Metastasis; 1703 Prednisone® (Male Patient); 1574 Carcinomatous Meningitis; 1704 Selective Serotonin Reuptake Inhibitors (SSRIs) Liver Metastasis; 1705 (Female Patient); 1540 Lung Metastasis; 1706 Selective Serotonin Reuptake Inhibitors (SSRIs) Pleural Effusion; 1707 (Male Patient); 1575 Recurrent Breast Cancer; 1709 Subcutaneous (S.Q.) Injection Instructions; 1541 Spinal Cord Compression; 1709 Talzenna® (talazoparib tosylate) (Female Patient); Why Chemotherapy Is Necessary; 1710 15015 Why Did My Cancer Metastasize After Talzenna® (talazoparib tosylate) (Male Patient); Chemotherapy?; 1711 15016 Why Did My Cancer Metastasize?; 1712 Taxol® (paclitaxel) (Female Patient); 1542 Taxol® (paclitaxel) (Male Patient); 1576 Patient Support Taxotere® (docetaxel) (Female Patient); 1543 American Cancer Society Screening Guidelines: Taxotere® (docetaxel) (Male Patient); 1577 Breast Cancer; 1801 TECENTRIQ® (atezolizumab); 15017 Contraception During Breast Cancer Treatment; Tykerb® (lapatinib); 1544 1802 Velban® (vinblastine) (Female Patient); 1545 Depression After Cancer; 1803 Velban® (vinblastine) (Male Patient); 1578 Employment Issues During Breast Cancer Treatment; 1804 Vepesid®, VP-16® (etoposide) (Female Patient); 1546 Exercise Prescription After Breast Cancer; 1805 Vepesid®, VP-16® (etoposide) (Male Patient); 1579 Facing the Future After a Breast Cancer Diagnosis; 1806 Verzenio® (abemaciclib) (Female Patient); 1599 ® Follow-Up Care After Breast Cancer: Monitoring Your Verzenio (abemaciclib) (Male Patient); 15011 Future Health (Female Patient); 1807 ® Xanax (alprazolam) (Female Patient); 1547 Follow-Up Care After Breast Cancer: Monitoring Your ® Xanax (alprazolam) (Male Patient); 1580 Future Health (Male Patient); 1821 Xeloda® (capecitabine) (Female Patient); 1548 Grief and Loss After Breast Cancer; 1808 Xeloda® (capecitabine) (Male Patient); 1581 Learning to Relax; 1810 Xgeva® (denosumab) (Female Patient); 1560 Living Wills - Advanced Directives; 1811 Xgeva® (denosumab) (Male Patient); 1582 Managing Finances During Treatment: Insured and Zinecard® (dexrazoxane); 1552 Non-Insured; 1809 Zofran®, Zofran ODT® (ondansetron); 1549

© 2021 page 7 of 8 Monitoring Dietary Fat; 1812 Energy Healing; 2009 My Prayer During Breast Cancer; 1813 Hypnotherapy; 2010 Newly Diagnosed Patient Navigation Guide; 1814 Journaling; 2011 Pregnancy After Breast Cancer; 1815 Massage Therapy; 2012 Prosthesis Selection; 1816 Meditation; 2013 Reading Recommendations; 1817 Music Therapy; 2014 Recurrent and Metastatic Patient Navigation Guide; Reflexology; 2015 1823 NEW Yoga; 2016 Resources for Breast Cancer Patients; 1818 Sexuality After Breast Cancer (Female Patient); Breast Health Navigator Tools 1819 Breast Health Navigator: Patient Assessment; 2101 Sexuality After Breast Cancer (Male Patient); 1822 Breast Health Navigator: Patient Monthly Contact Sexuality and the Single Woman; 1820 Record; 2102 Breast Health Navigator: Patient Weekly Contact Family Support Record; 2103 After Your Mother’s or Sister’s Breast Cancer; 1901 Patient Appointment Worksheet; 2104 Comfort Measures for the Homebound Patient; 1902 Patient Assessment: Questions for the Healthcare Helping Someone You Love Who Has Cancer; 1903 Team; 2105 Message to Family Members of Cancer Patients; Patient Communication Planner; 2106 1904 Patient Contact Permission Form; 2107 My Daughter’s Breast Cancer; 1905 Patient Information Needs Assessment; 2108 Support Partner Guide; 1906 Patient Treatment Barriers Assessment; 2109 The Dying Patient: A Caregiver’s Guide; 1907 Sample Letter: Breast Health Navigator Introduction; 2110 Complementary Therapies Sample Letter: Evaluation of Breast Health Navigator Acupuncture; 2017 Services; 2111 Alternative and Complementary Therapies for Sample Letter: Explanation of the Breast Health Cancer; 2001 Navigator Role; 2112 Aromatherapy; 2002 Art Therapy; 2003 Patient Records Biofeedback; 2004 Breast Cancer Diagnostic History; 2201 Cancer Treatment Terminology and Information Breast Cancer Treatment Record; 2202 Resources; 2005 Breast Health History; 2203 Chiropractic; 2006 Family Cancer History Assessment; 2204 Counseling and Psychotherapy; 2007 Healthcare Team Record; 2205 Update Diet Therapies; 2008 Patient Surveillance Recommendations; 2206

COPE Library: Breast Health Edition

Revision Date: 04.2021 Topic Count: 594

© 2021 page 8 of 8